L&K Biomed Ltd. (KOSDAQ:156100)
South Korea · Delayed Price · Currency is KRW 6,210.00
-50.00 (-0.80%)
At close: Oct 2, 2026
L&K Biomed Market Cap
L&K Biomed has a market cap or net worth of 138.8 billion as of October 2, 2026. Its market cap has decreased by -15.45% in one year.
Market Cap
138.80B
Enterprise Value
139.57B
Revenue
39.94B
Ranking
n/a
PE Ratio
48.30
Stock Price
6,210.00
ChartMarket Cap Chart
Since November 30, 2016, L&K Biomed's market cap has increased from 114.44B to 138.80B, an increase of 21.29%. That is a compound annual growth rate of 1.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 138.80B | -49.08% |
| Dec 30, 2025 | 272.58B | 106.21% |
| Dec 30, 2024 | 132.18B | -34.87% |
| Dec 28, 2023 | 202.96B | 89.01% |
| Dec 29, 2022 | 107.38B | -25.42% |
| Dec 30, 2021 | 143.97B | -71.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Next Biomedical | 274.81B |
| ASTERASYS Co.,Ltd | 234.04B |
| MEDIANA Co.,Ltd | 186.91B |
| Mezoo | 146.15B |
| Hironic | 80.49B |
| Remed | 77.81B |
| SELVAS Healthcare | 69.69B |
| DRGEM | 56.33B |